213 related articles for article (PubMed ID: 29220529)
1. Oxytocin and Naltrexone Successfully Treat Hypothalamic Obesity in a Boy Post-Craniopharyngioma Resection.
Hsu EA; Miller JL; Perez FA; Roth CL
J Clin Endocrinol Metab; 2018 Feb; 103(2):370-375. PubMed ID: 29220529
[TBL] [Abstract][Full Text] [Related]
2. Craniopharyngioma and hypothalamic obesity in children.
Vinchon M; Weill J; Delestret I; Dhellemmes P
Childs Nerv Syst; 2009 Mar; 25(3):347-52. PubMed ID: 19057910
[TBL] [Abstract][Full Text] [Related]
3. Weight gain in craniopharyngioma--a model for hypothalamic obesity.
Ahmet A; Blaser S; Stephens D; Guger S; Rutkas JT; Hamilton J
J Pediatr Endocrinol Metab; 2006 Feb; 19(2):121-7. PubMed ID: 16562584
[TBL] [Abstract][Full Text] [Related]
4. Management of Hypothalamic Obesity.
Müller HL
Endocrinol Metab Clin North Am; 2020 Sep; 49(3):533-552. PubMed ID: 32741487
[TBL] [Abstract][Full Text] [Related]
5. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.
Müller HL
Curr Opin Endocrinol Diabetes Obes; 2016 Feb; 23(1):81-9. PubMed ID: 26574645
[TBL] [Abstract][Full Text] [Related]
6. Treatment of Hypothalamic Obesity with Dextroamphetamine: A Case Series.
Denzer C; Denzer F; Lennerz BS; Vollbach H; Lustig RH; Wabitsch M
Obes Facts; 2019; 12(1):91-102. PubMed ID: 30844799
[TBL] [Abstract][Full Text] [Related]
7. Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.
Müller HL; Bueb K; Bartels U; Roth C; Harz K; Graf N; Korinthenberg R; Bettendorf M; Kühl J; Gutjahr P; Sörensen N; Calaminus G
Klin Padiatr; 2001; 213(4):244-9. PubMed ID: 11528558
[TBL] [Abstract][Full Text] [Related]
8. 'Do no harm': management of craniopharyngioma.
Gleeson H; Amin R; Maghnie M
Eur J Endocrinol; 2008 Dec; 159 Suppl 1():S95-9. PubMed ID: 18775978
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.
van Iersel L; Brokke KE; Adan RAH; Bulthuis LCM; van den Akker ELT; van Santen HM
Endocr Rev; 2019 Feb; 40(1):193-235. PubMed ID: 30247642
[TBL] [Abstract][Full Text] [Related]
10. Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up.
Müller HL; Gebhardt U; Teske C; Faldum A; Zwiener I; Warmuth-Metz M; Pietsch T; Pohl F; Sörensen N; Calaminus G;
Eur J Endocrinol; 2011 Jul; 165(1):17-24. PubMed ID: 21490122
[TBL] [Abstract][Full Text] [Related]
11. Oxytocin in survivors of childhood-onset craniopharyngioma.
Daubenbüchel AM; Hoffmann A; Eveslage M; Özyurt J; Lohle K; Reichel J; Thiel CM; Martens H; Geenen V; Müller HL
Endocrine; 2016 Nov; 54(2):524-531. PubMed ID: 27585663
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case-control study with 2 years of follow-up.
Wijnen M; Olsson DS; van den Heuvel-Eibrink MM; Wallenius V; Janssen JA; Delhanty PJ; van der Lely AJ; Johannsson G; Neggers SJ
Int J Obes (Lond); 2017 Feb; 41(2):210-216. PubMed ID: 27795552
[TBL] [Abstract][Full Text] [Related]
13. Parent observed neuro-behavioral and pro-social improvements with oxytocin following surgical resection of craniopharyngioma.
Cook N; Miller J; Hart J
J Pediatr Endocrinol Metab; 2016 Aug; 29(8):995-1000. PubMed ID: 27166717
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors for Hypothalamic Obesity in Patients With Adult-Onset Craniopharyngioma: A Consecutive Series of 120 Cases.
Wu W; Sun Q; Zhu X; Xiang B; Zhang Q; Miao Q; Wang Y; Li Y; Ye H
Front Endocrinol (Lausanne); 2021; 12():694213. PubMed ID: 34394000
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal study on growth and body mass index before and after diagnosis of childhood craniopharyngioma.
Müller HL; Emser A; Faldum A; Bruhnken G; Etavard-Gorris N; Gebhardt U; Oeverink R; Kolb R; Sörensen N
J Clin Endocrinol Metab; 2004 Jul; 89(7):3298-305. PubMed ID: 15240606
[TBL] [Abstract][Full Text] [Related]
16. Tumor origin and growth pattern at diagnosis and surgical hypothalamic damage predict obesity in pediatric craniopharyngioma.
Park SW; Jung HW; Lee YA; Shin CH; Yang SW; Cheon JE; Kim IO; Phi JH; Kim SK; Wang KC
J Neurooncol; 2013 Jul; 113(3):417-24. PubMed ID: 23579339
[TBL] [Abstract][Full Text] [Related]
17. Liraglutide 3mg as a weight-loss strategy after failed bariatric surgery in a patient with hypothalamic obesity following craniopharyngioma.
Bretault M; Carette C; Zaharia R; Vychnevskaia K; Bouillot JL; Czernichow S; Raffin-Sanson ML
Diabetes Metab; 2020 Nov; 46(6):514-515. PubMed ID: 31362076
[No Abstract] [Full Text] [Related]
18. For Debate: Should Bariatric Surgery be Performed in Children and Adolescents with Hypothalamic Obesity?
Stolbova S; Benes M; Petruzelkova L; Lebl J; Kolouskova S
Pediatr Endocrinol Rev; 2017 Jun; 14(4):348-352. PubMed ID: 28613044
[TBL] [Abstract][Full Text] [Related]
19. Hypothalamic obesity.
Babcock Gilbert S; Roth LW
Minerva Endocrinol; 2015 Mar; 40(1):61-70. PubMed ID: 25370939
[TBL] [Abstract][Full Text] [Related]
20. Is bariatric surgery really inefficient in hypothalamic obesity?
Gatta B; Nunes ML; Bailacq-Auder C; Etchechoury L; Collet D; Tabarin A
Clin Endocrinol (Oxf); 2013 Apr; 78(4):636-8. PubMed ID: 22994633
[No Abstract] [Full Text] [Related]
[Next] [New Search]
